NCT07120698 2026-01-05
CTONG 2508
Guangdong Association of Clinical Trials
Phase 2 Recruiting
Clinical Trials
10 trialsNCT06512207 2025-09-09
A Study on the Efficacy of Androgen Deprivation Therapy Combined With Anti-PD-1 Therapy in Advanced Lung Cancer
Jinzhou Medical University
Phase NA Recruiting
NCT05549037 2025-02-19
PACIFIC15
Hunan Province Tumor Hospital
Phase 3 Recruiting
NCT05504278 2025-01-27
Efficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1 Recruiting
NCT03872661 2024-12-06
NIBCUN
Sun Yat-sen University
Phase 2 Recruiting
NCT04973293 2024-11-19
Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer
Ruijin Hospital
Phase NA Recruiting
NCT05979818 2024-11-19
BRIO
Second Xiangya Hospital of Central South University
Phase 1 Recruiting
NCT06479759 2024-06-28
ACCLAIM
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Recruiting
NCT05004974 2024-03-12
Sintilimab With Pemigatinib in Patients With PD-L1-positive and FGFR Mutated Advanced Non-small Cell Lung Cancer
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Phase 2 Recruiting
NCT04728724 2023-09-13
Neoadjuvant Immunotherapy for Stage III Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Recruiting